Atlas Trials

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Clinical trial NCT02358889 · COMPLETED

Trial details

NCT number
NCT02358889
Sponsor
Iconic Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Choroidal NeovascularizationAge-related Macular Degeneration
Start date
2015-02-01
Primary completion
2016-09-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.